The +$5.1 Billion Global Molecular Imaging Market - Outlook to 2023
DUBLIN, Sept. 14, 2018 /PRNewswire/ --
The "Molecular Imaging Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The molecular imaging market is projected to grow at a CAGR of 6.25% to reach US$5.151 billion by 2023, from US$3.579 billion in 2017.
Rising prevalence of such disorders along with growing aging population has driven demand for molecular imaging significantly. Technological advancements in the medical sector will further contribute to the market growth. Growing adoption of hybrid molecular imaging systems is expected to provide a great opportunity for the expansion of the market across potential regional markets.
Geographically, North America dominates the global molecular imaging market while the Asia Pacific is expected to be the fastest growing market in the years ahead owing to rising healthcare spending in emerging economies of the region.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market.
The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions.
Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Key Topics Covered
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Force Analysis
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. MOLECULAR IMAGING MARKET BY DEVICE TYPE
5.1. Positron Emission Tomography (PET) Scanner
5.2. Single Photon Emission Computed Tomography (SPECT) Scanner
5.3. Gamma Camera
5.4. Nuclear Magnetic Resonance (NMR) Spectrometer
5.5. Others
6. MOLECULAR IMAGING MARKET BY APPLICATION
6.1. Cardiovascular
6.2. Neurology
6.3. Respiratory
6.4. Oncology
6.5. Others
7. MOLECULAR IMAGING MARKET BY END USER
7.1. Hospitals
7.2. Ambulatory Surgical Centers
7.3. Diagnostic Imaging Centers
8. MOLECULAR IMAGING MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.3. Europe
8.4. Middle East and Africa
8.5. Asia Pacific
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. GE Healthcare
10.2. Siemens Healthcare GmbH
10.3. Koninklijke Philips N.V.
10.4. Hologic Inc.
10.5. Shimadzu Corporation
10.6. Hitachi High-Technologies Corporation
10.7. Canon Medical System Corporation
10.8. Esaote SpA
For more information about this report visit https://www.researchandmarkets.com/research/2l38tz/the_5_1_billion?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/the-5-1-billion-global-molecular-imaging-market---outlook-to-2023--300712992.html
SOURCE Research and Markets
